We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$110B
AUM Growth
+$18.7B
Cap. Flow
+$7.09B
Cap. Flow %
6.45%
Top 10 Hldgs %
8.73%
Holding
3,883
New
532
Increased
1,751
Reduced
1,105
Closed
465

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$618M
2
VALE icon
Vale
VALE
+$332M
3
CELG
Celgene Corp
CELG
+$309M
4
CME icon
CME Group
CME
+$306M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 16.17%
2 Technology 14.41%
3 Consumer Discretionary 10.61%
4 Financials 10.51%
5 Real Estate 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCR
3101
DELISTED
CONSOL Coal Resources LP
CCR
$292K ﹤0.01%
16,500
-39,407
-70% -$702K
TOO
3102
DELISTED
Teekay Offshore Partners L.P.
TOO
$292K ﹤0.01%
243,600
-202,300
-45% -$256K
GLP icon
3103
Global Partners
GLP
$1.68B
$291K ﹤0.01%
14,806
-18,794
-56% -$347K
PPH icon
3104
VanEck Pharmaceutical ETF
PPH
$959M
$291K ﹤0.01%
4,800
+800
+20% +$47.3K
APEX
3105
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$291K ﹤0.01%
13,840
-3
-0% -$67
ZKIN icon
3106
ZK International Group
ZKIN
$77.4M
$288K ﹤0.01%
26,563
+25,106
+1,723% +$270K
IGOV icon
3107
iShares International Treasury Bond ETF
IGOV
$1.53B
$287K ﹤0.01%
5,862
-1,108
-16% -$54K
DON icon
3108
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$286K ﹤0.01%
+8,000
New +$279K
CVU icon
3109
CPI Aerostructures
CVU
$66.2M
$285K ﹤0.01%
43,900
+14,300
+48% +$98.6K
PLBC icon
3110
Plumas Bancorp
PLBC
$427M
$285K ﹤0.01%
12,500
-1,700
-12% -$41K
ENFY
3111
DELISTED
Enlightify Inc
ENFY
$285K ﹤0.01%
48,758
+5,091
+12% +$34K
ONCT
3112
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$282K ﹤0.01%
+1,677
New +$250K
RGLS
3113
DELISTED
Regulus Therapeutics
RGLS
$281K ﹤0.01%
27,569
+11,562
+72% +$126K
TANH icon
3114
Tantech Holdings
TANH
$6.07M
$279K ﹤0.01%
19
-11
-37% -$175K
RNTX
3115
Rein Therapeutics
RNTX
$63.1M
$279K ﹤0.01%
7,166
-2,883
-29% -$89.8K
NEOS
3116
DELISTED
Neos Therapeutics, Inc
NEOS
$279K ﹤0.01%
+106,968
New +$251K
BHVN
3117
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$278K ﹤0.01%
+5,400
New +$233K
OBE
3118
Obsidian Energy
OBE
$716M
$277K ﹤0.01%
144,075
-29,411
-17% -$78.3K
RBNC
3119
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$277K ﹤0.01%
12,425
-4,200
-25% -$93.5K
MTNB icon
3120
Matinas BioPharma
MTNB
$1.88M
$276K ﹤0.01%
+5,060
New +$273K
CTHR
3121
DELISTED
Charles & Colvard Ltd
CTHR
$276K ﹤0.01%
24,227
+2,440
+11% +$24.2K
EPU icon
3122
iShares MSCI Peru and Global Exposure ETF
EPU
$537M
$275K ﹤0.01%
+7,000
New +$265K
TOVX icon
3123
Theriva Biologics
TOVX
$9.64M
$273K ﹤0.01%
1,607
+204
+15% +$33.8K
PDS
3124
Precision Drilling
PDS
$999M
$271K ﹤0.01%
+5,673
New +$257K
GOLD
3125
Gold.com Inc
GOLD
$1.2B
$270K ﹤0.01%
45,400
+8,400
+23% +$52.6K

Similar funds

Renaissance Technologies's Q1 2019 Portfolio in Review

As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.

  • Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
  • Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
  • Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
  • Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
  • Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
  • Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
  • Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.